DE602004029393D1 - Tgf-beta1-bindende und geträgerte peptide - Google Patents
Tgf-beta1-bindende und geträgerte peptideInfo
- Publication number
- DE602004029393D1 DE602004029393D1 DE602004029393T DE602004029393T DE602004029393D1 DE 602004029393 D1 DE602004029393 D1 DE 602004029393D1 DE 602004029393 T DE602004029393 T DE 602004029393T DE 602004029393 T DE602004029393 T DE 602004029393T DE 602004029393 D1 DE602004029393 D1 DE 602004029393D1
- Authority
- DE
- Germany
- Prior art keywords
- peptides
- supported
- tgf
- preferred embodiments
- supported peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Dermatology (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51815403P | 2003-11-06 | 2003-11-06 | |
US52040303P | 2003-11-13 | 2003-11-13 | |
US53095403P | 2003-12-19 | 2003-12-19 | |
US53120703P | 2003-12-19 | 2003-12-19 | |
US53118903P | 2003-12-19 | 2003-12-19 | |
PCT/US2004/036979 WO2005046710A2 (en) | 2003-11-06 | 2004-11-06 | Tgf-beta binding and supported peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004029393D1 true DE602004029393D1 (de) | 2010-11-11 |
Family
ID=34596198
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004029393T Active DE602004029393D1 (de) | 2003-11-06 | 2004-11-06 | Tgf-beta1-bindende und geträgerte peptide |
DE602004029812T Active DE602004029812D1 (de) | 2003-11-06 | 2004-11-06 | Fgf-5-bindende und geträgerte peptide |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004029812T Active DE602004029812D1 (de) | 2003-11-06 | 2004-11-06 | Fgf-5-bindende und geträgerte peptide |
Country Status (9)
Country | Link |
---|---|
US (8) | US20080113917A1 (de) |
EP (4) | EP1692158B1 (de) |
JP (2) | JP4843497B2 (de) |
AT (4) | ATE513917T1 (de) |
CA (1) | CA2544820C (de) |
DE (2) | DE602004029393D1 (de) |
DK (2) | DK1680507T3 (de) |
ES (1) | ES2375360T3 (de) |
WO (4) | WO2005047314A2 (de) |
Families Citing this family (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2292641B1 (de) * | 2003-11-06 | 2017-12-06 | Danisco US Inc. | Expression in faserigen Pilzen von Proteasehemmern und Varianten davon |
DE602004029393D1 (de) * | 2003-11-06 | 2010-11-11 | Danisco Us Inc | Tgf-beta1-bindende und geträgerte peptide |
WO2006044650A2 (en) * | 2004-10-15 | 2006-04-27 | Genencor International, Inc. | Competitive differential screening |
US9084734B2 (en) * | 2005-05-05 | 2015-07-21 | Danisco Us Inc. | Peptide personal care compositions and methods for their use |
DK1904529T3 (da) * | 2005-06-10 | 2010-11-15 | Medical Res Council | Anvendelse af Stefin A som et scaffoldprotein |
KR20080042070A (ko) * | 2005-07-13 | 2008-05-14 | 암젠 마운틴 뷰 인코포레이티드 | Il-6 결합 단백질 |
GB0601684D0 (en) * | 2006-01-27 | 2006-03-08 | Reckitt Benckiser Uk Ltd | Composition, process for preparation and method of use |
WO2007092465A2 (en) * | 2006-02-07 | 2007-08-16 | Dyao Pharmaceutical Corporation | Topical delivery compositions |
PT2061313E (pt) * | 2006-09-16 | 2013-09-23 | Soy Labs Llc | Produtos e métodos que usam péptidos de soja para reduzir os níveis de colesterol total e de colesterol ldl |
US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
US20080090745A1 (en) * | 2006-10-13 | 2008-04-17 | Fox Bryan P | Expression of Streptomyces subtilism inhibitor (SSI) proteins in Bacillus and Streptomyces sp. |
EP2094842B1 (de) * | 2006-12-18 | 2012-06-13 | Danisco US Inc. | Neue laccasen, zusammensetzungen und verwendungsverfahren dafür |
WO2008088493A2 (en) | 2006-12-21 | 2008-07-24 | Danisco Us, Inc., Genencor Division | Compositions and uses for an alpha-amylase polypeptide of bacillus species 195 |
CA2690055A1 (en) * | 2007-06-06 | 2008-12-18 | Danisco Us Inc. | Methods for improving protein performance |
US20090048136A1 (en) * | 2007-08-15 | 2009-02-19 | Mcdonald Hugh C | Kappa-carrageenase and kappa-carrageenase-containing compositions |
RU2010121829A (ru) * | 2007-10-31 | 2011-12-10 | ДАНИСКО ЮЭс ИНК. (US) | Применение и получение нейтральных металлопротеаз на фоне, свободном от сериновых протеаз |
US20090221030A1 (en) * | 2007-11-01 | 2009-09-03 | Kai Bao | Signal sequences and co-expressed chaperones for improving protein production in a host cell |
GB0722332D0 (en) * | 2007-11-14 | 2007-12-27 | Reckitt Benckiser Uk Ltd | Personal care article |
WO2009096916A1 (en) * | 2008-01-29 | 2009-08-06 | Genencor International, Inc. | Expression of streptomyces subtilisin inhibitor (ssi) proteins in bacillus and streptomyces sp. |
AU2009212526A1 (en) | 2008-02-04 | 2009-08-13 | Danisco Us Inc. | TS23 alpha-amylase variants with altered properties |
US7803902B2 (en) | 2008-10-15 | 2010-09-28 | Danisco Us Inc. | Modified variant bowman birk protease inhibitors |
CN102245635B (zh) * | 2008-10-15 | 2016-08-31 | 丹尼斯科美国公司 | 修饰的变体bowman birk蛋白酶抑制剂 |
US7772181B2 (en) | 2008-10-15 | 2010-08-10 | Danisco Us Inc. | Personal care compositions comprising modified variant Bowman Birk Protease Inhibitors |
US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
US20120172275A1 (en) | 2009-03-10 | 2012-07-05 | Danisco Us Inc. | Bacillus Megaterium Strain DSM90-Related Alpha-Amylases, and Methods of Use, Thereof |
US20100247693A1 (en) * | 2009-03-24 | 2010-09-30 | Marini Jan L | Cosmetic formulation to treat rosacea telangiectasia |
EP2417254B1 (de) | 2009-04-08 | 2014-05-21 | Danisco US Inc. | Alpha-amylasen in verbindung mit halomonas-stamm wdg195 sowie verfahren zur verwendung davon |
US8530218B2 (en) * | 2009-04-24 | 2013-09-10 | Danisco Us Inc. | Proteases with modified pro regions |
MX2011011619A (es) * | 2009-05-01 | 2012-02-28 | Signal Invest And Man Co | Composicion antimicrobiana hidratante. |
AR076941A1 (es) | 2009-06-11 | 2011-07-20 | Danisco Us Inc | Cepa de bacillus para una mayor produccion de proteina |
US20110052676A1 (en) * | 2009-09-01 | 2011-03-03 | James Vincent Gruber | Composition For Delaying Cellular Senescence |
EP2478003A4 (de) | 2009-09-15 | 2013-05-29 | Five Prime Therapeutics Inc | Haarwuchsverfahren unter verwendung extrazellulärer fgfr4-domänen |
GB0921001D0 (en) | 2009-11-30 | 2010-01-13 | Aqua Bio Technology Asa | Products and uses |
US8728790B2 (en) | 2009-12-09 | 2014-05-20 | Danisco Us Inc. | Compositions and methods comprising protease variants |
US8685931B2 (en) | 2009-12-17 | 2014-04-01 | Five Prime Therapeutics, Inc. | Hair growth methods using FGFR3 extracellular domains |
CN102781459A (zh) * | 2009-12-30 | 2012-11-14 | 索莱有限责任公司 | 从大豆工艺流中分离的纯化的鲍曼-贝克蛋白酶抑制剂蛋白 |
US8771669B1 (en) | 2010-02-09 | 2014-07-08 | David Gordon Bermudes | Immunization and/or treatment of parasites and infectious agents by live bacteria |
US9597379B1 (en) | 2010-02-09 | 2017-03-21 | David Gordon Bermudes | Protease inhibitor combination with therapeutic proteins including antibodies |
US8524220B1 (en) | 2010-02-09 | 2013-09-03 | David Gordon Bermudes | Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
US9687591B2 (en) | 2010-03-31 | 2017-06-27 | Agency For Science, Technology And Research | Building stratified biomimetic tissues and organs using crosslinked ultrashort peptide hydrogel membranes |
US8999916B2 (en) | 2010-03-31 | 2015-04-07 | Agency For Science, Technology And Research | Crosslinked peptide hydrogels |
ES2574056T3 (es) * | 2010-03-31 | 2016-06-14 | Agency For Science, Technology And Research | Péptido/peptoide anfifílico lineal e hidrogel que comprende el mismo |
EP2558573B1 (de) | 2010-04-15 | 2017-02-22 | Danisco US Inc. | Zusammensetzungen und verfahren mit proteasevarianten |
HUE034524T2 (en) | 2010-05-06 | 2018-02-28 | Procter & Gamble | Consumer articles with protease variants |
US8481038B2 (en) | 2010-11-15 | 2013-07-09 | Five Prime Therapeutics, Inc. | Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins |
EP3486319B1 (de) | 2011-05-05 | 2022-11-30 | Danisco US Inc. | Zusammensetzungen und verfahren mit serinproteasevarianten |
MX357386B (es) | 2011-05-05 | 2018-07-06 | Procter & Gamble | Composiciones y metodos que comprenden variantes de proteasa serina. |
CN103781903A (zh) | 2011-08-31 | 2014-05-07 | 丹尼斯科美国公司 | 包含脂肪分解酶变体的组合物和方法 |
US20150017700A1 (en) | 2011-12-22 | 2015-01-15 | Danisco Us Inc. | Compositions and methods comprising a lipolytic enzyme variant |
US9120841B2 (en) | 2012-09-28 | 2015-09-01 | Agency For Science, Technology And Research | Amphiphilic linear peptidepeptoid and hydrogel comprising the same |
AU2013328953A1 (en) | 2012-10-12 | 2015-03-26 | Danisco Us Inc. | Compositions and methods comprising a lipolytic enzyme variant |
CN104781400A (zh) | 2012-11-05 | 2015-07-15 | 丹尼斯科美国公司 | 包含嗜热菌蛋白酶变体的组合物和方法 |
EP2935573A1 (de) | 2012-12-19 | 2015-10-28 | Danisco US Inc. | Neuartige mannase, zusammensetzungen und verfahren zur verwendung davon |
US9593339B1 (en) | 2013-02-14 | 2017-03-14 | David Gordon Bermudes | Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment |
EP3882346A1 (de) | 2013-05-29 | 2021-09-22 | Danisco US Inc. | Neuartige metalloproteasen |
US20160122738A1 (en) | 2013-05-29 | 2016-05-05 | Danisco Us Inc. | Novel metalloproteases |
US20160108387A1 (en) | 2013-05-29 | 2016-04-21 | Danisco Us Inc. | Novel metalloproteases |
EP3004314B1 (de) | 2013-05-29 | 2018-06-20 | Danisco US Inc. | Neuartige metalloproteasen |
MX2020001159A (es) | 2013-07-19 | 2021-07-07 | Danisco Us Inc | Composiciones y metodos que comprenden una variante de enzima lipolitica. |
US20160222368A1 (en) | 2013-09-12 | 2016-08-04 | Danisco Us Inc. | Compositions and Methods Comprising LG12-CLADE Protease Variants |
KR20160068855A (ko) * | 2013-10-11 | 2016-06-15 | 제넨테크, 인크. | Nsp4 억제제 및 사용 방법 |
CN105813695A (zh) | 2013-11-01 | 2016-07-27 | 斯弗尤姆生物制药有限公司 | 用于透皮递送治疗剂和美容剂的包含体 |
DK3514230T3 (da) | 2013-12-13 | 2021-11-15 | Danisco Us Inc | Serinproteaser af bacillus-arter |
EP3080263B1 (de) | 2013-12-13 | 2019-07-03 | Danisco US Inc. | Serinproteasen des bazillus gibsonii-clade |
US9737592B1 (en) * | 2014-02-14 | 2017-08-22 | David Gordon Bermudes | Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment |
DK3119884T3 (da) | 2014-03-21 | 2019-10-14 | Danisco Us Inc | Serinproteaser af bacillus-arter |
WO2016061438A1 (en) | 2014-10-17 | 2016-04-21 | Danisco Us Inc. | Serine proteases of bacillus species |
EP3957729A1 (de) | 2014-10-27 | 2022-02-23 | Danisco US Inc. | Serinproteasen |
US20180010074A1 (en) | 2014-10-27 | 2018-01-11 | Danisco Us Inc. | Serine proteases of bacillus species |
DK3212781T3 (da) | 2014-10-27 | 2019-12-16 | Danisco Us Inc | Serinproteaser |
EP4403631A2 (de) | 2014-10-27 | 2024-07-24 | Danisco US Inc. | Serinproteasen |
DK3212662T3 (da) | 2014-10-27 | 2020-07-20 | Danisco Us Inc | Serinproteaser |
US20180216090A1 (en) | 2015-03-12 | 2018-08-02 | Danisco Us Inc. | Compositions and methods comprising lg12-clade protease variants |
WO2016183509A1 (en) | 2015-05-13 | 2016-11-17 | Danisco Us Inc. | AprL-CLADE PROTEASE VARIANTS AND USES THEREOF |
EP4234693A3 (de) | 2015-06-17 | 2023-11-01 | Danisco US Inc | Bacillus-gibboni-clade-serin-proteasen |
JP7134629B2 (ja) | 2015-06-17 | 2022-09-12 | ダニスコ・ユーエス・インク | 改変プロペプチド領域を備えるプロテアーゼ |
CN107022432A (zh) * | 2016-01-29 | 2017-08-08 | 高露洁-棕榄公司 | 清洁组合物 |
WO2017192300A1 (en) | 2016-05-05 | 2017-11-09 | Danisco Us Inc | Protease variants and uses thereof |
CN109477112A (zh) | 2016-05-31 | 2019-03-15 | 丹尼斯科美国公司 | 蛋白酶变体及其用途 |
EP3472313B1 (de) | 2016-06-17 | 2022-08-31 | Danisco US Inc. | Proteasevarianten und verwendungen davon |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
EP3559226B1 (de) | 2016-12-21 | 2023-01-04 | Danisco US Inc. | Bacillus-gibboni-clade-serin-proteasen |
US20200392477A1 (en) | 2016-12-21 | 2020-12-17 | Danisco Us Inc. | Protease variants and uses thereof |
US11298391B1 (en) * | 2017-04-27 | 2022-04-12 | Lorenol Laboratories, Inc. | Topical skin health improvement compositions and administrations thereof |
EP3717643A1 (de) | 2017-11-29 | 2020-10-07 | Danisco US Inc. | Subtilisin-varianten mit verbesserter stabilität |
WO2019245704A1 (en) | 2018-06-19 | 2019-12-26 | Danisco Us Inc | Subtilisin variants |
US20210363470A1 (en) | 2018-06-19 | 2021-11-25 | Danisco Us Inc | Subtilisin variants |
WO2020046613A1 (en) | 2018-08-30 | 2020-03-05 | Danisco Us Inc | Compositions comprising a lipolytic enzyme variant and methods of use thereof |
CN112368388B (zh) * | 2018-10-31 | 2024-01-02 | 青岛蔚蓝生物集团有限公司 | 一种生产具有蛋白酶抗性的洗涤用酶的方法 |
EP3887515A1 (de) | 2018-11-28 | 2021-10-06 | Danisco US Inc. | Subtilisin-varianten mit verbesserter stabilität |
EP3976776A1 (de) | 2019-05-24 | 2022-04-06 | Danisco US Inc. | Subtilisin-varianten und verwendungsverfahren |
CN112062828B (zh) * | 2019-06-10 | 2022-04-29 | 温州医科大学 | Fgf-5多肽抑制剂及其生发应用 |
US20230049452A1 (en) | 2020-01-13 | 2023-02-16 | Danisco Us Inc | Compositions comprising a lipolytic enzyme variant and methods of use thereof |
US20240034960A1 (en) | 2020-08-27 | 2024-02-01 | Danisco Us Inc | Enzymes and enzyme compositions for cleaning |
CN113307857B (zh) * | 2021-01-14 | 2022-11-01 | 艾时斌 | 从表皮生长因子、凝集素和Tat蛋白衍生的支架蛋白 |
WO2023278297A1 (en) | 2021-06-30 | 2023-01-05 | Danisco Us Inc | Variant lipases and uses thereof |
CN117916354A (zh) | 2021-09-03 | 2024-04-19 | 丹尼斯科美国公司 | 用于清洁的衣物洗涤组合物 |
WO2023114939A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2023114932A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2023114936A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
CN118369414A (zh) | 2021-12-16 | 2024-07-19 | 宝洁公司 | 包含蛋白酶的自动盘碟洗涤组合物 |
CA3240638A1 (en) | 2021-12-16 | 2023-06-22 | Michelle Jackson | Fabric and home care composition comprising a protease |
WO2023168234A1 (en) | 2022-03-01 | 2023-09-07 | Danisco Us Inc. | Enzymes and enzyme compositions for cleaning |
WO2024050343A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Subtilisin variants and methods related thereto |
WO2024050346A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Detergent compositions and methods related thereto |
WO2024102698A1 (en) | 2022-11-09 | 2024-05-16 | Danisco Us Inc. | Subtilisin variants and methods of use |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3755560A (en) * | 1971-06-30 | 1973-08-28 | Dow Chemical Co | Nongreasy cosmetic lotions |
US3929678A (en) * | 1974-08-01 | 1975-12-30 | Procter & Gamble | Detergent composition having enhanced particulate soil removal performance |
JPS51125468A (en) | 1975-03-27 | 1976-11-01 | Sanyo Chem Ind Ltd | Method of preparing resins of high water absorbency |
US4152416A (en) * | 1976-09-17 | 1979-05-01 | Marra Dorothea C | Aerosol antiperspirant compositions delivering astringent salt with low mistiness and dustiness |
US4421769A (en) * | 1981-09-29 | 1983-12-20 | The Procter & Gamble Company | Skin conditioning composition |
FI69503C (fi) * | 1984-03-13 | 1986-02-10 | Neste Oy | Ytbelagd bergsbehaollare eller tunnel |
US5411873A (en) * | 1984-05-29 | 1995-05-02 | Genencor, Inc. | Process for producing heterologous polypeptides |
US4965188A (en) * | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US5679543A (en) * | 1985-08-29 | 1997-10-21 | Genencor International, Inc. | DNA sequences, vectors and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi |
US4999186A (en) * | 1986-06-27 | 1991-03-12 | The Procter & Gamble Company | Novel sunscreen agents, sunscreen compositions and methods for preventing sunburn |
US4937370A (en) * | 1987-06-02 | 1990-06-26 | The Procter & Gamble Company | Novel chromophores, sunscreen compositions and methods for preventing sunburn |
US5322770A (en) * | 1989-12-22 | 1994-06-21 | Hoffman-Laroche Inc. | Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription |
WO1988002025A1 (en) * | 1986-09-17 | 1988-03-24 | Sri International | Expression vectors for bacilli |
US5087372A (en) * | 1989-03-24 | 1992-02-11 | Asahi Kasei Kogyo Kabushiki Kaisha | Method for removing heavy metal ions from contaminated water and a porous membrane usable therefor |
US5011681A (en) * | 1989-10-11 | 1991-04-30 | Richardson-Vicks, Inc. | Facial cleansing compositions |
US5073372A (en) * | 1990-11-30 | 1991-12-17 | Richardson-Vicks, Inc. | Leave-on facial emulsion compositions |
US5073371A (en) * | 1990-11-30 | 1991-12-17 | Richardson-Vicks, Inc. | Leave-on facial emulsion compositions |
US5436228A (en) * | 1990-12-12 | 1995-07-25 | Postlethwaite; Arnold E. | Chemotactic wound healing peptides |
US5429950A (en) * | 1992-03-30 | 1995-07-04 | Genencor International, Inc. | Heterologous gene expression in bacillus subtilis: fusion approach |
GB9415421D0 (en) | 1994-07-30 | 1994-09-21 | Procter & Gamble | Cosmetic compositions and processes for manufacture thereof |
AU709850B2 (en) | 1994-11-28 | 1999-09-09 | Procter & Gamble Company, The | Topical skin care compositions containing thickened polyol carboxylic acid esters as skin conditioning agents |
AU5713896A (en) * | 1996-03-12 | 1997-10-01 | Genencor International, Inc. | Alkaline cellulase and method of producing same |
EP0991422A1 (de) * | 1996-04-18 | 2000-04-12 | The General Hospital Corporation | Modulierende interaktionen des epitheliums und des mesenchyms |
US5827508A (en) * | 1996-09-27 | 1998-10-27 | The Procter & Gamble Company | Stable photoprotective compositions |
US5976838A (en) * | 1996-12-18 | 1999-11-02 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
AU734338B2 (en) | 1996-11-22 | 2001-06-14 | Procter & Gamble Company, The | Cosmetic compositions |
DE19735587B4 (de) * | 1997-08-16 | 2012-03-22 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Peptid mit radioprotektiver Wirkung, dieses enthaltende kosmetische oder pharmazeutische Zusammensetzung, für dieses kodierende Nukleinsäure, Herstellungsverfahren für dieses Peptid und die Verwendung als radioprotektives Agens |
US6747137B1 (en) * | 1998-02-13 | 2004-06-08 | Genome Therapeutics Corporation | Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics |
EA003637B1 (ru) * | 1998-07-20 | 2003-08-28 | Инокселл А/С | Новые способы идентификации биомолекул лигандов и мишеней |
US5935556A (en) * | 1998-07-30 | 1999-08-10 | The Procter & Gamble Company | Sunscreen compositions |
US5989528A (en) | 1998-07-30 | 1999-11-23 | The Procter & Gamble Company | Sunscreen compositions |
JP3855042B2 (ja) * | 1998-09-22 | 2006-12-06 | 独立行政法人産業技術総合研究所 | 毛髪の鑑別法 |
US5968485A (en) * | 1998-10-16 | 1999-10-19 | The Procter & Gamble Company | UV protection compositions |
US5972316A (en) * | 1998-10-16 | 1999-10-26 | The Procter & Gamble Company | UV protection compositions |
AU1275599A (en) | 1998-10-23 | 2000-05-15 | Procter & Gamble Company, The | Skin care compositions |
GB9825854D0 (en) * | 1998-11-25 | 1999-01-20 | Univ Bristol | Peptide |
JP3106191B1 (ja) * | 1999-03-30 | 2000-11-06 | 工業技術院長 | Fgf−5の生理的機能制御ペプチド及び該ペプチドを含有する医薬組成物 |
US7090973B1 (en) * | 1999-04-09 | 2006-08-15 | Oscient Pharmaceuticals Corporation | Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics |
US20100293669A2 (en) * | 1999-05-06 | 2010-11-18 | Jingdong Liu | Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
US20040031072A1 (en) * | 1999-05-06 | 2004-02-12 | La Rosa Thomas J. | Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement |
US6872563B1 (en) * | 1999-10-05 | 2005-03-29 | President And Fellows Of Harvard College | Compositions and methods for production of disulfide bond containing proteins in host cells |
US20020001825A1 (en) * | 2000-03-31 | 2002-01-03 | Nobuyuki Itoh | Fibroblast growth factor-like molecules and uses thereof |
JP4966470B2 (ja) * | 2000-04-14 | 2012-07-04 | ダニスコ・ユーエス・インコーポレーテッド | 選択性標的化方法 |
US20110131679A2 (en) * | 2000-04-19 | 2011-06-02 | Thomas La Rosa | Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
WO2002002621A2 (en) * | 2000-06-30 | 2002-01-10 | Zymogenetics, Inc. | Mammalian secreted proteins |
US6537968B1 (en) * | 2000-07-24 | 2003-03-25 | Alphamed Pharmaceuticals Corp | Treatment of lupus erythematosus |
JP4493271B2 (ja) * | 2000-12-13 | 2010-06-30 | アナフォア インコーポレイテッド | C型レクチン様ドメインの骨格構造を有する蛋白質のコンビナトリアルライブラリ |
US7214786B2 (en) * | 2000-12-14 | 2007-05-08 | Kovalic David K | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
EP1379549A2 (de) * | 2001-02-07 | 2004-01-14 | Institut Pasteur | Genomsequenz des photorhabdus luminescens stamms tt01 und verwendungen |
WO2004072223A2 (en) * | 2003-02-11 | 2004-08-26 | Institut Pasteur | Identification and characterization of racemases, definition of protein signatures, and a test for detecting d-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase |
DE602004029393D1 (de) * | 2003-11-06 | 2010-11-11 | Danisco Us Inc | Tgf-beta1-bindende und geträgerte peptide |
EP2292641B1 (de) * | 2003-11-06 | 2017-12-06 | Danisco US Inc. | Expression in faserigen Pilzen von Proteasehemmern und Varianten davon |
US7319142B1 (en) * | 2004-08-31 | 2008-01-15 | Monsanto Technology Llc | Nucleotide and amino acid sequences from Xenorhabdus and uses thereof |
US7803902B2 (en) * | 2008-10-15 | 2010-09-28 | Danisco Us Inc. | Modified variant bowman birk protease inhibitors |
US7772181B2 (en) * | 2008-10-15 | 2010-08-10 | Danisco Us Inc. | Personal care compositions comprising modified variant Bowman Birk Protease Inhibitors |
-
2004
- 2004-11-06 DE DE602004029393T patent/DE602004029393D1/de active Active
- 2004-11-06 AT AT04800809T patent/ATE513917T1/de not_active IP Right Cessation
- 2004-11-06 DK DK04800809.8T patent/DK1680507T3/da active
- 2004-11-06 CA CA2544820A patent/CA2544820C/en not_active Expired - Fee Related
- 2004-11-06 DE DE602004029812T patent/DE602004029812D1/de active Active
- 2004-11-06 AT AT04810432T patent/ATE482972T1/de not_active IP Right Cessation
- 2004-11-06 EP EP04810431A patent/EP1692158B1/de not_active Not-in-force
- 2004-11-06 WO PCT/US2004/036980 patent/WO2005047314A2/en active Application Filing
- 2004-11-06 EP EP04800809A patent/EP1680507B1/de active Active
- 2004-11-06 AT AT04818640T patent/ATE486087T1/de not_active IP Right Cessation
- 2004-11-06 EP EP04810432A patent/EP1692159B1/de not_active Not-in-force
- 2004-11-06 JP JP2006539676A patent/JP4843497B2/ja not_active Expired - Fee Related
- 2004-11-06 DK DK04810431.9T patent/DK1692158T3/da active
- 2004-11-06 AT AT04810431T patent/ATE530560T1/de not_active IP Right Cessation
- 2004-11-06 ES ES04810431T patent/ES2375360T3/es active Active
- 2004-11-06 WO PCT/US2004/036981 patent/WO2005047511A2/en active Application Filing
- 2004-11-06 WO PCT/US2004/036976 patent/WO2005046709A2/en active Application Filing
- 2004-11-06 EP EP04818640A patent/EP1692160B1/de not_active Not-in-force
- 2004-11-06 US US10/581,142 patent/US20080113917A1/en not_active Abandoned
- 2004-11-06 WO PCT/US2004/036979 patent/WO2005046710A2/en active Application Filing
- 2004-11-08 US US10/984,410 patent/US7485618B2/en not_active Expired - Fee Related
- 2004-11-08 US US10/984,270 patent/US7524816B2/en not_active Expired - Fee Related
- 2004-11-08 US US10/984,514 patent/US7413877B2/en active Active
-
2008
- 2008-02-19 US US12/033,848 patent/US20080269139A1/en not_active Abandoned
- 2008-07-14 US US12/172,921 patent/US7696173B2/en active Active
-
2009
- 2009-03-12 US US12/403,272 patent/US20110230405A1/en not_active Abandoned
-
2011
- 2011-08-19 JP JP2011179629A patent/JP5728329B2/ja active Active
-
2012
- 2012-09-10 US US13/609,116 patent/US20130065829A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE482972T1 (de) | Tgf-beta1-bindende und geträgerte peptide | |
ECSP044996A (es) | Agentes de contraste de objetivo multimérico basado en péptido | |
CY1111225T1 (el) | Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c | |
ATE542920T1 (de) | Modifiziertes menschliches wachstumshormon | |
CY1105616T1 (el) | ΠΕΠΤΙΔΙΑ ΑΝΑΣΤΟΛΕΙΣ ΤΟΥ TGFβ1 | |
DE602004011770D1 (de) | Fusionsproteine | |
DK1434791T3 (da) | Specifikke bindingsmidler til human angiopoietin-2 | |
EA200701448A1 (ru) | Специфически связывающаяся с крипто-антигеном человека молекула (варианты), композиция на ее основе (варианты), способ получения молекулы, способ лечения посредством молекулы (варианты) и способ ингибирования крипто-экспрессии в клетке больного | |
CY1111212T1 (el) | Θειικες ενωσεις ως αναστολεις της πρωτεασης σερινης ns3 του ιου της ηπατιτιδας γ | |
ATE424842T1 (de) | Proteine der bcl-2-familie und fragmente davon, und ihre verwendung bei krebspatienten | |
DK1534830T3 (da) | In vito-peptid-ekspressionsbibliotek | |
CY1112267T1 (el) | Νεα πεπτιδια ως αναστολεις πρωτεασης ns3-σερινης του ιου ηπατιτιδας c | |
ATE382364T1 (de) | Von igf-bindungsprotein stammendes peptid | |
ATE504602T1 (de) | Für humane matriptase spezifische bindungsproteine | |
HRP20050024A2 (en) | Pegylated t20 polypeptide | |
EA200801180A1 (ru) | Селективные пептидные агонисты рецептора vpac2 | |
CY1111285T1 (el) | Θεραπεια αυτοανοσων ασθενειων | |
ATE466080T1 (de) | Formulierungen und verfahren zum denaturieren von proteinen | |
ATE363531T1 (de) | Claudin polypeptide | |
WO2004002418A3 (en) | Compositions and methods comprising protein activated receptor antagonists | |
WO2003087138A3 (en) | Methods for identifying polypeptide factors interacting with rna | |
DE602005013650D1 (de) | Proteinhydrolysat zur behandlung von müdigkeit | |
EA200600042A1 (ru) | Способы образования дисульфидных связей и гликозилирования белков и реагенты, применяемые в этих способах | |
DE602004015142D1 (de) | Antiangiogene peptide zur behandlung oder vorbeugung von endometriose | |
ATE368687T1 (de) | Thrombopoietinproteine mit verbesserten eigenschaften |